Halberd Corporation (HALB)
OTCMKTS · Delayed Price · Currency is USD
0.0019
+0.0001 (2.70%)
Sep 12, 2025, 3:08 PM EDT
Halberd Market Cap
Halberd has a market cap or net worth of $1.27 million as of September 12, 2025. Its market cap has decreased by -70.63% in one year.
Market Cap
1.27M
Enterprise Value
n/a
Revenue
6.94K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 25, 2009, Halberd's market cap has decreased from 2.61M to 1.27M, a decrease of -51.27%. That is a compound annual growth rate of -4.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 1.27M | -50.07% |
| Dec 31, 2024 | 2.54M | -11.40% |
| Dec 29, 2023 | 2.87M | -4.05% |
| Dec 30, 2022 | 2.99M | -62.35% |
| Dec 31, 2021 | 7.95M | -4.69% |
| Dec 31, 2020 | 8.34M | 1,228.60% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 781.22M |
| Elite Pharmaceuticals | 736.80M |
| Tian'an Technology Group | 732.84M |
| Glass House Brands | 577.09M |
| Northwest Biotherapeutics | 376.88M |
| CytoDyn | 367.97M |
| American Oncology Network | 346.29M |